English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/71831
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex

AuthorsMartínez-Rodríguez, Ricardo; Toledano Gasca, Adolfo ; Álvarez-Vicente, María Isabel ; Turégano, L.; Colman, O.; Rosés, P.; Gómez de Segura, I.; Miguel, E. de
Issue Date2003
PublisherJohn Wiley & Sons
CitationJournal of Neuroscience Research 73: 708-716 (2003)
AbstractNicotine/nicotine agonists, which have been proposed as therapeutic agents for the treatment of Alzheimer's disease and other neurodegenerative disorders, produce a wide variety of effects on the nervous system. Some mechanisms involved remain poorly understood. In this work, immunohistochemical techniques were used to determine the effect of nicotine on nerve growth factor (NGF) in the frontoparietal (motor, somatosensory) brain cortex of the albino rat. Nicotine was chronically administered intraperitoneally using osmotic pumps (0.35 mg nicotine base/kg body weight/day for 14 days). An increase in the number and the immunoreaction intensity of NGF-like positive pyramidal and nonpyramidal neurons of these cortical areas was observed after treatment. Immunopositive astroglial cells were always seen in sections of treated animals but not in controls. The neuropil of control animals was, in general, devoid of reaction, but in treated animals, immunopositive prolongations were located randomly, some in close association with capillaries. At the electron microscopic level, these prolongations were demonstrated as belonging to neurons (dendrites and axons) and astroglial cells. Nicotinic activation of selected neurons and glial cells seems to trigger NGF/neurotrophic mechanisms, suggesting their use may be of benefit in prevention and treatment of neurodegenerative diseases. © 2003 Wiley-Liss, Inc.
URIhttp://hdl.handle.net/10261/71831
DOI10.1002/jnr.10688
Identifiersdoi: 10.1002/jnr.10688
issn: 0360-4012
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.